CG

Cutler Group Portfolio holdings

AUM $198M
1-Year Return 27.33%
This Quarter Return
+6.26%
1 Year Return
+27.33%
3 Year Return
+39.6%
5 Year Return
+161.34%
10 Year Return
AUM
$1.63B
AUM Growth
+$207M
Cap. Flow
+$105M
Cap. Flow %
6.46%
Top 10 Hldgs %
36.07%
Holding
3,903
New
518
Increased
985
Reduced
1,002
Closed
586

Sector Composition

1 Communication Services 12.17%
2 Technology 11.73%
3 Healthcare 11.4%
4 Energy 9.18%
5 Consumer Staples 8.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
QGENF
2601
DELISTED
QIAGEN NV
QGENF
$2K ﹤0.01%
+100
New +$2K
TRX icon
2602
TRX Gold Corp
TRX
$144M
$2K ﹤0.01%
3,237
ACM icon
2603
Aecom
ACM
$16.8B
$1K ﹤0.01%
36
ANY icon
2604
Sphere 3D
ANY
$19.8M
$1K ﹤0.01%
2
APT icon
2605
Alpha Pro Tech
APT
$51.2M
$1K ﹤0.01%
400
ASM
2606
Avino Silver & Gold Mines
ASM
$640M
$1K ﹤0.01%
+668
New +$1K
ATNI icon
2607
ATN International
ATNI
$238M
$1K ﹤0.01%
21
AXTI icon
2608
AXT Inc
AXTI
$169M
$1K ﹤0.01%
200
AZTA icon
2609
Azenta
AZTA
$1.36B
$1K ﹤0.01%
+100
New +$1K
BAK icon
2610
Braskem
BAK
$1.33B
$1K ﹤0.01%
118
-1,910
-94% -$16.2K
BRO icon
2611
Brown & Brown
BRO
$30.9B
$1K ﹤0.01%
92
-590
-87% -$6.41K
BWEN icon
2612
Broadwind
BWEN
$51.6M
$1K ﹤0.01%
352
-500
-59% -$1.42K
CADE icon
2613
Cadence Bank
CADE
$7.02B
$1K ﹤0.01%
76
CNK icon
2614
Cinemark Holdings
CNK
$3.25B
$1K ﹤0.01%
29
-157
-84% -$5.41K
COHU icon
2615
Cohu
COHU
$964M
$1K ﹤0.01%
100
CORT icon
2616
Corcept Therapeutics
CORT
$7.68B
$1K ﹤0.01%
300
DGICA icon
2617
Donegal Group Class A
DGICA
$711M
$1K ﹤0.01%
+98
New +$1K
DRRX icon
2618
DURECT Corp
DRRX
$1K ﹤0.01%
80
-160
-67% -$2K
DSWL icon
2619
Deswell Industries
DSWL
$66.1M
$1K ﹤0.01%
900
-100
-10% -$111
ENSG icon
2620
The Ensign Group
ENSG
$9.69B
$1K ﹤0.01%
55
-1,114
-95% -$20.3K
ZYNE
2621
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$1K ﹤0.01%
+100
New +$1K
ERJ icon
2622
Embraer
ERJ
$10.5B
$1K ﹤0.01%
70
-395
-85% -$5.64K
EWC icon
2623
iShares MSCI Canada ETF
EWC
$3.26B
$1K ﹤0.01%
+60
New +$1K
FTI icon
2624
TechnipFMC
FTI
$16.4B
$1K ﹤0.01%
63
GALT icon
2625
Galectin Therapeutics
GALT
$344M
$1K ﹤0.01%
1,000
-900
-47% -$900